Inovio Pharmaceuticals, Inc. (LON:0A43)
2.175
-0.015 (-0.68%)
At close: Feb 18, 2025
Inovio Pharmaceuticals Revenue
Inovio Pharmaceuticals had revenue of $203.41K USD in the twelve months ending September 30, 2024, down -76.18% year-over-year. In the year 2023, Inovio Pharmaceuticals had annual revenue of $832.01K, down -91.89%.
Revenue (ttm)
$203.41K
Revenue Growth
-76.18%
P/S Ratio
n/a
Revenue / Employee
$1.67K
Employees
122
Market Cap
63.97M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 832.01K | -9.43M | -91.89% |
Dec 31, 2022 | 10.26M | 8.49M | 478.23% |
Dec 31, 2021 | 1.77M | -5.64M | -76.05% |
Dec 31, 2020 | 7.41M | 3.30M | 80.24% |
Dec 31, 2019 | 4.11M | -26.37M | -86.51% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 43.19B |
Shell | 227.10B |
HSBC Holdings | 48.93B |
Unilever | 50.25B |
Rio Tinto Group | 42.86B |
RELX PLC | 9.43B |
BP p.l.c. | 149.68B |
British American Tobacco p.l.c. | 25.87B |
Inovio Pharmaceuticals News
- 10 days ago - Inovio Pharmaceuticals Inc (INO) Oppenheimer 35th Annual Healthcare Life Sciences Conference (Transcript) - Seeking Alpha
- 11 days ago - Inovio respiratory DNA drug candidate shows promise in early trial - Seeking Alpha
- 11 days ago - Clinical and Immunological Results from Phase 1/2 Study of INO-3107 as a Treatment for Recurrent Respiratory Papillomatosis Published in Nature Communications - PRNewsWire
- 13 days ago - Immune Response Data for INO-3107 to be Presented as a Poster at American Association for Cancer Research Immuno-Oncology (AACR-IO) Conference - PRNewsWire
- 24 days ago - INOVIO to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference - PRNewsWire
- 6 weeks ago - INOVIO Highlights Anticipated 2025 Milestones and 2024 Key Accomplishments - PRNewsWire
- 6 weeks ago - Why Inovio Pharmaceuticals (INO) Stock Is Skyrocketing - Benzinga
- 6 weeks ago - Top 3 Health Care Stocks That Could Blast Off This Month - Benzinga